ANDA 85584, held by Watson Laboratories. Quinidine Sulfate.
As of Nov 21, 2026, ANDA 85584 (Quinidine Sulfate), held by Watson Laboratories, was first approved by FDA on Jun 9, 1981, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 9, 1981 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Quinidine Sulfate100MG · tablet;oral | Quinidine Sulfate | Discontinued |
| Jun 10, 1996 | Supplement 16Labeling | Approved | None posted |
| Jun 5, 1989 | Supplement 12Labeling | Approved | None posted |
| Dec 23, 1988 | Supplement 11Labeling | Approved | None posted |
| Jun 9, 1981 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters